This suggests that elevated CSNK1A1 expression might be linked to a reduced presence of these immune effector cells in the tumor, potentially contributing to an immune-suppressive environment that could allow the tumor to evade immune surveillance. The gene discussed is CSNK1A1; the disease is neoplasm.